Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Pfizer names oncology head Chris Boshoff as R&D chief

admin by admin
November 20, 2024
in Stock
0
Pfizer names oncology head Chris Boshoff as R&D chief
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

(Reuters) – Pfizer (NYSE:PFE) said on Wednesday it has named company veteran and oncology head Chris Boshoff as its chief of research and development.

The appointment comes at a time when Pfizer is facing criticism from activist investor Starboard for overspending on big acquisitions and failing to produce profitable new drugs from those deals or its internal research and development.

The New York-based drugmaker, under CEO Albert Bourla, poured money into new deals to bolster its business, which has been struggling with a sharp fall in sales of its COVID vaccine and antiviral Paxlovid from the pandemic highs.

Pfizer, which is now looking to strengthen its focus on cancer drugs, said Boshoff will take on the role of chief scientific officer starting Jan. 1 and oversee all functions of research & development across all therapeutic areas.

Most recently Pfizer’s chief oncology officer, Boshoff, also served as chief development officer for oncology and rare diseases, and as head of development in Japan across all therapeutic areas at Pfizer.

He has been with Pfizer for more than 11 years and has overseen the approval of 24 innovative medicines and biosimilars in more than 30 conditions.

Boshoff will replace Mikael Dolsten, a key figure behind the development of Pfizer’s COVID-19 vaccine, who stepped down from the role earlier this year after a more than 15-year career at the drugmaker.

Roger Dansey, who joined Pfizer through the 2023 $43-billion Seagen acquisition, will serve as the interim chief oncology officer, the company said.

The drugmaker added Johanna Bendell, who will join the company from Roche in 2025, will take on the role as oncology chief development officer.

This post appeared first on investing.com

Previous Post

Delta Air eyes mid single-digit revenue growth in 2025 with premium travel in focus

Next Post

Delta Air Lines is in the ‘best fundamental shape it has ever been in’

admin

admin

Next Post
Delta Air Lines is in the ‘best fundamental shape it has ever been in’

Delta Air Lines is in the ‘best fundamental shape it has ever been in’

Trending News

Can China’s steel output sustain growth with new market stimulus?

Can China’s steel output sustain growth with new market stimulus?

November 15, 2024
US solar stocks sink as Trump tax bill threatens green energy lifelines

US solar stocks sink as Trump tax bill threatens green energy lifelines

May 22, 2025
Canada’s unemployment rate hits 6.9% as US tariffs undermine export sectors

Canada’s unemployment rate hits 6.9% as US tariffs undermine export sectors

May 10, 2025
Subscribe to Insightful Word


    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025
    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    August 7, 2025
    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    Goldman Sachs boosts Nvidia price target to $200 ahead of Q2 earnings

    August 7, 2025

    Recent News

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    Dow futures soar 250 points today: 5 things to know before Wall Street opens

    August 7, 2025
    Affirm stock price is rising: is it a buy before earnings?

    Affirm stock price is rising: is it a buy before earnings?

    August 7, 2025

    Latest News

    • Dow futures soar 250 points today: 5 things to know before Wall Street opens
    • Affirm stock price is rising: is it a buy before earnings?
    • Intel stock plunges sharply after Trump calls on CEO to resign: here’s why rebound may take time

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.